ClinConnect ClinConnect Logo
Search / Trial NCT03959163

The Validity of the Quick Renal MRI in Pediatric Kidney Disease

Launched by UNIVERSITY OF WISCONSIN, MADISON · May 20, 2019

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new imaging method called the quick renal MRI, which aims to provide a faster, safer way to look at children's kidneys without the need for injections, sedation, or radiation. The goal is to see if this new MRI technique is as accurate as the traditional DMSA scan, which is currently used to check for kidney infections and scarring. If the quick renal MRI proves to be effective, it could make testing easier and less stressful for children with kidney issues.

Children from birth to 21 years old who are being treated for kidney infections or have had multiple urinary tract infections may be eligible to participate. Depending on which part of the study they are in, participants can expect to be involved for anywhere from one week to six months. It's important to know that some children may not qualify if they show certain conditions in their urine tests or are not comfortable with the MRI procedure. Overall, this trial could lead to better ways to evaluate kidney health in children.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Aim 1:
  • Patient is admitted to American Family Children's Hospital for a febrile UTI, suspected pyelonephritis, or diagnosed pyelonephritis
  • Undergoing clinical DMSA scan
  • * Aim 2:
  • Undergoing DMSA scans as a part of their routine clinical care
  • History of more than one UTI in the past year
  • Exclusion Criteria:
  • * Aim 1:
  • No evidence of pyuria on their urine analysis
  • Negative urine culture
  • Not comfortable with having a Quick MRI performed
  • * Both aims:
  • Contraindications to MRI

About University Of Wisconsin, Madison

The University of Wisconsin-Madison is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, including cutting-edge facilities and a diverse pool of expert researchers, to conduct rigorous studies that address critical health challenges. The institution's focus on translating research findings into practical applications fosters the development of new treatments and interventions, ultimately contributing to improved patient outcomes and public health initiatives. As a sponsor of clinical trials, the University of Wisconsin-Madison is dedicated to upholding the highest ethical standards and ensuring participant safety throughout the research process.

Locations

Madison, Wisconsin, United States

Patients applied

0 patients applied

Trial Officials

Shannon Cannon, MD

Principal Investigator

University of Wisconsin, Madison

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials